Breast Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with ER+ and/or PR+ breast cancer with pathological immunohistochemistry results; 2. The pathological stage is I.~III.; 3. Oral third-generation aromatase inhibitors (such as letrozole, anastrozole, exemestane, etc.); 4. Menopausal status; 5. Have complete clinical data; 6. Those who have certain comprehension and language expression skills and are willing to participate in this study
Exclusion criteria
Exclusion criteria: 1. Patients with serious impairment of the function of other important organs (such as liver, lungs, kidneys) or a history of other malignant tumors; 2. Patients with rheumatoid arthritis; 3. Recurrence or recurrence of breast cancer during treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life (QoL); | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom management self-efficacy; | — |
Countries
China
Contacts
Liaoning Cancer Hospital &Institute